Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

SWE-NEO : Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial

Helgadottir, Hildur ; Carneiro, Ana LU orcid ; Portelli, Francesca ; Papadakis, Konstantinos ; Björkström, Karl ; Yang, Muyi ; Johansson, Iva LU ; Svensson, Ingela Skogvall ; Jazrawi, Allan and Hallgren, Amanda , et al. (2026) In Acta Oncologica 65. p.126-130
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
CTLA-4, immune checkpoint inhibitors, ipilimumab, melanoma, neoadjuvant therapy, nivolumab, PD-1
in
Acta Oncologica
volume
65
pages
5 pages
publisher
Taylor & Francis
external identifiers
  • scopus:105030632695
  • pmid:41711492
ISSN
0284-186X
DOI
10.2340/1651-226X.2026.45174
language
English
LU publication?
yes
id
7ae17a4d-cb99-4dfe-90db-9ba5bfe54b9e
date added to LUP
2026-04-01 15:01:49
date last changed
2026-05-27 21:40:16
@article{7ae17a4d-cb99-4dfe-90db-9ba5bfe54b9e,
  author       = {{Helgadottir, Hildur and Carneiro, Ana and Portelli, Francesca and Papadakis, Konstantinos and Björkström, Karl and Yang, Muyi and Johansson, Iva and Svensson, Ingela Skogvall and Jazrawi, Allan and Hallgren, Amanda and Harbst, Katja and Bark, Rusana and Brage, Suzanne Egyhazi and Berglund, Anders and Isaksson, Karolin and Wickström, Stina and Nilsson, Jonas and Ny, Lars and Jönsson, Göran and Bagge, Roger Olofsson}},
  issn         = {{0284-186X}},
  keywords     = {{CTLA-4; immune checkpoint inhibitors; ipilimumab; melanoma; neoadjuvant therapy; nivolumab; PD-1}},
  language     = {{eng}},
  pages        = {{126--130}},
  publisher    = {{Taylor & Francis}},
  series       = {{Acta Oncologica}},
  title        = {{SWE-NEO : Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial}},
  url          = {{http://dx.doi.org/10.2340/1651-226X.2026.45174}},
  doi          = {{10.2340/1651-226X.2026.45174}},
  volume       = {{65}},
  year         = {{2026}},
}